If I am not mistaken and if ATH 434 Phase 2 results are stellar, I believe some regulatory agencies can waive the requirement for conducting the Phase 3 human trial and grant approval. Even if I am wrong, I don't think Phase 3 will take long to complete. I am also very hopeful that we very possibly might expect to receive some significant funding from the Michael J. Fox Parkinson's Fund and perhaps also from the multi-billion dollar Antibiotic Resistance Fund as Pivalde has mentioned which should immediately facilitate any research and testing that is necessary.
Ann: ATH Annual General Meeting Presentation, page-26
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(11.1%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $4.263K | 916.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 69165915 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 38212524 | 21 |
View Market Depth
| Last trade - 15.11pm 05/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |